This invention relates generally to in vitro diagnostic (IVD) test systems, and, more particularly, to optoelectronic test systems used in measuring biological compounds in body fluids.
IVD test systems are available for a wide variety of medical and environmental conditions. Several types of assay formats exist, all of which involve reacting a body fluid sample (such as saliva, blood, or urine) with a reagent to yield a physically detectable change. An example of such a test system is the Linear Flow Assay (LFA), which is commonly used for pregnancy tests. In this type of test system, a urine sample flows over a chemically treated material such as nitrocellulose located inside the testing device. The presence of an analyte in the urine sample generally results in a visually detectable coloring of a test strip which indicates pregnancy.
Since the intensities of the colors, labels, and markers in the various test systems can vary and can degrade rapidly after the reaction occurs, users of such tests may have difficulty in visually interpreting a test result. Therefore, several optoelectronic test systems have been developed to measure the color and/or intensity of the induced physical changes.
Three classes of optoelectronic test instruments have been developed to perform such testing. The first class includes large, highly accurate desktop units that use disposable single- or multiple-assay test substrates. A disadvantage of this class of test system is its high cost, which relegates these test systems to use in a few central laboratories, thus requiring shipment of samples which results in delays in processing and return of results. In addition, contaminants are required to be cleaned from such systems in between testing in order to prevent test corruption. Finally, the test substrate or sample container must be aligned correctly with the optical system for proper operation.
The second class of optoelectronic test systems are less expensive, hand-held, disposable units that enclose a single test substrate and are discarded after use. U.S. Pat. No. 5,837,546 to Allen, et al., discloses an example of this class of test system. The disadvantages of this class of test system include limited functionality, sensitivity, and dynamic range, and a relatively high cost on a per test basis, as the cost of the device cannot be amortized over multiple tests.
U.S. Pat. No. 5,656,503 discloses a hybrid class of optoelectrical test systems, as embodied in pregnancy test products of Unipath, LLC. Such systems are typically comprised of a disposable hand-held device containing instrumentation to illuminate and observe a fluid sample, but employ disposable test substrates. While less expensive than other test systems, this hybrid class similarly experiences the alignment and contamination problems of the desktop class.
Thus, there is a need to provide a low-cost optoelectronic test system which has a low risk of contamination in between sample tests and for which assuring the proper alignment of the illumination source and/or detection optics with the sample under test is not a necessary part of the test process.
The needs of the invention set forth above as well as further and other needs and advantages of the present invention are achieved by the embodiments of the invention described hereinbelow.
The present invention provides a rapid diagnostic assay test device, and method of use thereof, for determining whether a fluid under test contains a certain substance by sensing an optical change in the fluid (or test substrate). A test device in accordance with the present invention comprises a semi-disposable, two-part optoelectronic system that allows wide, point of care dissemination without the high initial cost, contamination or optical alignment problems of desktop devices.
In one embodiment, the test device includes a cartridge and a reader, wherein all optoelectronic elements involved in acquiring data from the fluid sample are integrated and optically aligned within the cartridge and only data is transferred between the cartridge and reader. The cartridge includes a reaction zone containing an analyte capture reagent that, when reacted with the fluid sample, induces an optical change in the sample, and at least one light source within the cartridge for emitting light incident upon the reaction zone. One or more optoelectronic sensors are positioned within the cartridge so as to detect light emanating from the reaction zone. The sensor(s) output data to the reader through a mateable interface. This interface also transfers power from the reader to the optoelectronic elements in the test cartridge. The reader includes a microprocessor that interprets the sensor data to generate test results.
The microprocessor may determine a time interval over which valid sensor data may be acquired from the cartridge, and may convey the test results to one or more external displays and/or databases through another interface such as, for example, a USB port or other serial connection. The microprocessor may also store the test results in non-volatile memory within the reader, and/or provide an indication, such as through one or more light emitting diodes or a liquid crystal display, of the test results. The microprocessor may also indicate the operational status of the reader through such means.
The present invention may be adapted to a variety of assay formats including, but not limited to, linear flow assays, optical immunoassays, micro-fluidic assays, and fluorescent label molecule assays. Certain of these assays operate by transporting the fluid sample to the reaction zone for reaction with the analyte capture reagent, whereas others involve directly dispensing the fluid sample into the reaction zone.
As will be described below, the test device is semi-disposable, in that the cartridge is intended to be single-use, whereas the reader is intended to be used multi-use. The test device optionally includes means for limiting the number of tests in which the reader may be utilized.
For a better understanding of the present invention, together with other and further objects thereof, reference is made to the accompanying drawings and detailed description and its scope will be pointed out in the appended claims.
The present invention provides a semi-disposable, rapid-diagnostic test device that allows wide, point-of-care dissemination without the high initial cost and contamination risks of desktop systems, or the optical alignment problems of low-cost, handheld assay systems, wherein any misalignment of a sample and a reader may result in greater errors than are acceptable. A hand-held test device 2 in accordance with the present invention is illustrated in
In the linear flow assay (LFA) embodiment of the invention illustrated in
A control line may also be embedded in the test strip. The control zone is a zone of the test strip in which an optical signal is formed irrespective of the presence or absence of the analyte of interest to show that the test has been correctly performed and/or that the binding reagents are functional. A reference zone may also be utilized, wherein only “background” signal is formed which can be used, for example, to calibrate the assay result reading device and/or to provide a background signal against which the test signal may be referenced. In such instances, a comparison is made between the intensity levels of the calibration or control lines (or zone), or some other reference standard, and the detection stripe(s) of the test strip, to calculate the amount of analyte present in a fluid sample.
At least one electro-optic sensor 28 is in fixed alignment with the reaction zone 10, optionally via a prism, lens 30 or other optical feature, in order to detect the presence and intensity of any change in radiation emanating from the reaction zone. As shown, the light emanating from the zone (or from multiple zones in certain embodiments) may be light which is reflected from the test strip 9 or, in the case of configurations utilizing test strips which are transparent or translucent, light which is transmitted through the test strip. In principle, an assay result reading device 2 in accordance with the present disclosure may comprise any number of light sources 25 and any number of photodetectors (sensors) 28. There may also be more than one reaction zone in the cartridge, reading multiple assay results. For the purposes of the present specification, light incident upon a particular zone of a test strip from a light source, and reflected by the strip or transmitted therethrough, may be regarded as “emanating” from the strip, although of course the light actually originates from the light source. The one or more light source 25 illuminating the reaction zone preferably comprises one or more light emitting diodes (LED's), diode lasers or other emitters tuned to an optimum wavelength. Light emanating from the reaction zone, indicative of the physical change induced in the fluid sample, is measured by the sensor(s) 28, which preferably is a PN, PIN, or avalanche photodiode, a CMOS or CCD imaging device, or any other device capable of detecting photons and complying with the size restraints for a hand-held instrument.
In one LFA embodiment of the device 2, the fluid sample dispensed upon the collection pad (receptor 12) is transported via capillary action along test strip 9 to the reaction zone 10. The liquid sample flows from the sample receptor 12 (not shown) in contact with one padded end 11 of test strip 9 through the reaction zone 10 to a padded second end 13. In general, the fluid sample flows through this mechanism one-way along the test strip 9. The padding “pulls” the liquid containing the analyte along the membrane from one end of the membrane to another end of the membrane, through the reaction zone, where any of the analyte to be detected that is present in the fluid sample is bound to the analyte capture reagent(s) immobilized on one or more stripes. The test strip 9 may be composed of a standard cellulose ester, with nitrocellulose usually providing good results. Notably, all of the optical components required to illuminate and detect the presence and intensity of the optical change induced in the fluid sample are fixed in alignment in the disposable cartridge 4, while the electronics for processing (microprocessor 20) and storing and/or indicating the results of the test are packaged in the semi-disposable, multi-use reader 6.
It is to be understood that the invention can be configured for detecting a broad range of analytes, including therapeutic drugs, drugs of abuse, hormones, vitamins, glucose proteins (including antibodies of all classes), peptides, steroids, bacteria or bacterial infection, fungi, viruses, parasites, components or products of bacteria, allergens of all types, antigens of all types, products or components of normal or malignant cells, and the like.
The description above of an LFA embodiment of the invention is by no means intended to be limiting. Optical immuno, micro-fluidic, and fluorescent label molecule assay embodiments of the invention, for example, are considered to be within the scope of the invention. No sample receptor or fluid transport mechanisms are employed in optical immunoassay (OIA) embodiments of the present invention, wherein the fluid sample under test is directly deposited upon an optically reflective substrate (through a sample input window/port) with an analyte-binding capture reagent. In an OIA embodiment, rather than being composed of nitrocellulose material as is the test strip of the LFA embodiment, the test substrate is composed of an optically reflective surface such as, for example, silicon and the like, upon which have been formed thin molecular films of silicon or non-silicon reagents. The surface of the test substrate is optically aligned with one or more light sources and one or more photodetectors. Light emitted from the light source(s) is incident upon the substrate in the reaction zone, and the change in the reflection of light through the fluid sample and molecular thin films on the substrate is detected and one or more signals associated with the change is generated.
In micro-fluidic assay (MFA) embodiments of the invention, the reaction between the fluid sample and the analyte capture reagent is performed in a bulk fluidic state in a well or other container occupying the reaction zone, and the resulting change in light emanating from the reaction zone is similarly detected by one or more photodetectors optically aligned with the reaction zone and light source(s), all the aforementioned components being integrated within the cartridge 4. As above, the detected change in light emanating from the reaction zone results in generation of a sensor output signal (e.g., a voltage and/or current) indicative of the change, which is made available to the reader for processing into test results.
With reference again to
With reference to the functional diagram of
With reference again to
In certain embodiments, the cartridge circuitry 14 includes an electrical component (EEPROM 40) outputting a data code or serial number uniquely identifying the cartridge 4 to the microprocessor 20. Additionally, or alternatively, each cartridge 4 may have a unique identifier on an external surface of the cartridge 4 such as, for example, a label or barcode 42, which preferably matches the serial number being output by EEPROM 40. As used herein, bar code refers to a printed horizontal strip of vertical bars of varying widths, groups of which represent decimal digits or other information and are used for identification purposes. The vertical bars are also referred to herein as stripes. Bar codes are read by a bar code reader or scanner and the code interpreted either through software or a hardware decoder. The bar code may be printed in inert ink, or might be printed on a transparent overlay so as not to interfere with the test itself. Such measures are useful in maintaining confidentiality of a patient's drug and disease test results, while preserving test traceability information. The cartridge identification data may be stored in non-volatile memory 36 with the associated test results and/or transmitted from the reader to an external database or display system by USB, RS-232, wireless (WI-FI, Bluetooth, RF-ID) or other serial connection. The cartridge identification data may also include information such as the type of test, the lot number, expiration date, calibration factors, and the like.
Although the invention has been described with respect to various embodiments, it should be realized this invention is also capable of a wide variety of further and other embodiments within the spirit and scope of the appended claims.